Utah Pilots AI Acne Prescriptions in Sandbox Expansion — SkimNews
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- Utah regulators announced a plan to let an AI product evaluate patients for mild-to-moderate acne and write new drug prescriptions without prior human review
- Nolla Health will launch an AI service that analyzes patient intake forms and skin photos to determine whether a low-risk drug is appropriate
- Nolla's pilot will begin with a licensed clinician reviewing AI decisions and signing off on prescriptions, though the company may eventually be allowed to prescribe without that review
- Nolla Health raised $4.5 million last year from investors including General Catalyst and aspires to direct AI treatment for a host of conditions beyond acne
- The pilot is part of a significant expansion of Utah's 'AI sandbox,' run by the Office of Artificial Intelligence Policy, which can waive regulations for companies testing AI products under state supervision
Why it matters: Utah's AI sandbox now covers AI-only prescribing for low-risk drugs like acne, with Nolla Health's $4.5M-backed platform as the first test case. If the clinician-review requirement is eventually dropped, the state establishes a regulatory template other states could scale—making Utah the proving ground for whether AI can replace a doctor at the prescription pad.
Ask SkimNews
